CP
PTEN icon

Covalent Partners’s Patterson-UTI PTEN Stock Holding History

Covalent Partners’s Portfolio PTEN Stock Details PTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-214,057
Closed -$2.46M – 20
2019
Q2 		$2.46M Sell
214,057
-126,000
-37% -$1.62M 4.75% 10
2019
Q1 		$4.77M Sell
340,057
-180,743
-35% -$2.37M 9.08% 5
2018
Q4 		$5.39M Buy
520,800
+233,965
+82% +$3.45M 8.71% 3
2018
Q3 		$4.91M Sell
286,835
-18,043
-6% -$310K 6.21% 8
2018
Q2 		$5.49M Buy
304,878
+21,558
+8% +$432K 5.88% 7
2018
Q1 		$4.96M Buy
+283,320
New +$5.91M 4.73% 11
2015
Q2 		– Sell
-285,000
Closed -$5.35M – 41
2015
Q1 		$5.35M Buy
+285,000
New +$4.89M 1.09% 29

Other funds holding PTEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JIM
JB Investments Management Phoenixville, Pennsylvania $763M AUM 110.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Covalent Partners's PTEN Position: Q3 2019 in Review

Covalent Partners sold out of Patterson-UTI (PTEN) in Q3 2019, closing a stake of 214,057 shares — an estimated $2.46M sold.

Covalent Partners first reported a position in PTEN in Q1 2015 and held it in 7 quarters. The position peaked at $5.49M in Q2 2018. 268 funds tracked by Wall St. Rank hold PTEN as of Q3 2019.

  • Covalent Partners reported no remaining Patterson-UTI position as of Q3 2019 after selling out during the quarter.
  • Covalent Partners sold 214,057 Patterson-UTI shares in Q3 2019, an estimated $2.46M.
  • Covalent Partners first reported a position in Patterson-UTI in Q1 2015 and held it in 7 quarters.
  • Covalent Partners's Patterson-UTI position peaked at $5.49M in Q2 2018.
  • 268 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2019.

Based on Covalent Partners's 13F filing for Q3 2019, filed 14 Nov 2019.